Press enter to see results or esc to cancel.


Enthera is a biotech company building a pipeline of first-in-class biologics for several underserved autoimmune conditions, with a focus on Type 1 Diabetes (T1D) and Inflammatory Bowel Disease (IBD). It aims to develop disease-modifying treatments by preserving and re-establishing cell and organ function to revert the outcome of these conditions. Enthera’s therapeutics are founded on …

Continue Reading